29 September 2020 - Investigators have concluded that fully realizing the cost-saving potential of biosimilars could “release enormous resources” for ...
15 June 2020 - Payers are increasingly calling for the value of new drugs to be measured explicitly. ...
6 December 2018 - The German market for innovative medicines is characterised by simultaneous underuse and overuse. ...
14 November 2018 - Germany’s health minister Jens Spahn has called for faster adoption of cheaper copies of biotech drugs ...